[unable to retrieve full-text content]
- Triple-action diabetes jab shown to reduce blood sugar and body weight The Guardian
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits Reuters
- Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications investor.lilly.com
- ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes Fierce Biotech
- A new wave of weight-loss therapies aims to be better than today’s GLP-1s MarketWatch
https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWjI4OFo2Z3JQUU5yeGR6Y1JyVVRKNU1uWjQ1aDdSbDBUMmJwb0FCX3JFVTNweVBjN1EteV9xTW0wbGotd0V5d0hRTHg0a0JUeHpydG9HejRnZGVpZnltc1NTb0lHckFEWkZRNFNuTmM4NnJaRV9pS3ZBV09OcnZRWGpDMGp1LTZmeEcyWkRpR0Y4VmJsWFhDQlI5cjJ2N3BoRTdOSVI2cmo?oc=5
2026-06-07 12:38:00Z
CBMiqAFBVV95cUxQWjI4OFo2Z3JQUU5yeGR6Y1JyVVRKNU1uWjQ1aDdSbDBUMmJwb0FCX3JFVTNweVBjN1EteV9xTW0wbGotd0V5d0hRTHg0a0JUeHpydG9HejRnZGVpZnltc1NTb0lHckFEWkZRNFNuTmM4NnJaRV9pS3ZBV09OcnZRWGpDMGp1LTZmeEcyWkRpR0Y4VmJsWFhDQlI5cjJ2N3BoRTdOSVI2cmo